Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues

doi:10.1084/jem.162.2.573

This Article

Full Text (PDF)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Galili, U.

Articles by Shohet, S. B.

Search for Related Content

PubMed

PubMed Citation

Articles by Galili, U.

Articles by Shohet, S. B.

Pubmed/NCBI databases

Compound via MeSH
Substance via MeSH

Social Bookmarking

What's this?

ARTICLES

Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues

U Galili, BA Macher, J Buehler and SB Shohet

A natural IgG antibody (anti-Gal) with alpha-galactosyl binding specificity has been found in large amounts (0.5 - 1.0% of serum IgG) in all individuals tested. It has been purified by affinity chromatography on a column of melibiose-Sepharose. In addition to its affinity for normal and pathological senescent human red cells, the antibody readily interacts with rabbit red blood cell (RRBC) glycolipids with alpha-galactosyl terminal residues. Two types (glycosidic linkages of 1----3 vs. 1----4) of rabbit red cells glycolipids with terminal alpha-galactosyl residues were tested for antibody binding. The antibody specifically bound to glycolipids with Gal alpha 1----3 terminal residues, and treatment of these glycolipids with alpha-galactosidase abolished binding. Hemagglutination inhibition studies with oligosaccharides of known structure also showed that the antibody binds specifically to glycoconjugates with an alpha 1----3 terminal galactose residue. Anti-Gal did not bind to a human B-active glycolipid, indicating that fucose-linked alpha 1----2 to the penultimate galactose prevents anti-Gal binding. The anti-Gal specificity for RRBC glycolipids also paralleled that of the alpha- galactosyl-specific Bandeiraea simplicifolia lectin. The possible reasons for the occurrence of this unique antibody in human serum are discussed.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Abdel-Motal, U. M., Guay, H. M., Wigglesworth, K., Welsh, R. M., Galili, U. (2007). Immunogenicity of Influenza Virus Vaccine Is Increased by Anti-Gal-Mediated Targeting to Antigen-Presenting Cells. J. Virol. 81: 9131-9141 [Abstract] [Full Text]
Sadoulet, M.-O., Franceschi, C., Aubert, M., Silvy, F., Bernard, J.-P., Lombardo, D., Mas, E. (2007). Glycoengineering of {alpha}Gal xenoantigen on recombinant peptide bearing the J28 pancreatic oncofetal glycotope. Glycobiology 17: 620-630 [Abstract] [Full Text]
Speak, A. O., Salio, M., Neville, D. C. A., Fontaine, J., Priestman, D. A., Platt, N., Heare, T., Butters, T. D., Dwek, R. A., Trottein, F., Exley, M. A., Cerundolo, V., Platt, F. M. (2007). From the Cover: Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc. Natl. Acad. Sci. USA 104: 5971-5976 [Abstract] [Full Text]
Galili, U., Wigglesworth, K., Abdel-Motal, U. M. (2007). Intratumoral Injection of {alpha}-gal Glycolipids Induces Xenograft-Like Destruction and Conversion of Lesions into Endogenous Vaccines. J. Immunol. 178: 4676-4687 [Abstract] [Full Text]
Ide, K., Wang, H., Tahara, H., Liu, J., Wang, X., Asahara, T., Sykes, M., Yang, Y.-G., Ohdan, H. (2007). Role for CD47-SIRP{alpha} signaling in xenograft rejection by macrophages. Proc. Natl. Acad. Sci. USA 104: 5062-5066 [Abstract] [Full Text]
Abdel-Motal, U., Wang, S., Lu, S., Wigglesworth, K., Galili, U. (2006). Increased Immunogenicity of Human Immunodeficiency Virus gp120 Engineered To Express Gal{alpha}1-3Gal{beta}1-4GlcNAc-R Epitopes. J. Virol. 80: 6943-6951 [Abstract] [Full Text]
Al-Mohanna, F., Saleh, S., Parhar, R. S., Khabar, K., Collison, K. (2005). Human neutrophil gene expression profiling following xenogeneic encounter with porcine aortic endothelial cells: the occult role of neutrophils in xenograft rejection revealed. J. Leukoc. Biol. 78: 51-61 [Abstract] [Full Text]
Mohiuddin, M. M., Ogawa, H., Yin, D.-P., Galili, U. (2003). Tolerance induction to a mammalian blood group--like carbohydrate antigen by syngeneic lymphocytes expressing the antigen, II: tolerance induction on memory B cells. Blood 102: 229-236 [Abstract] [Full Text]
Ogawa, H., Yin, D.-P., Shen, J., Galili, U. (2003). Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen. Blood 101: 2318-2320 [Abstract] [Full Text]
Unfer, R. C., Hellrung, D., Link, C. J. Jr. (2003). Immunity to the {alpha}(1,3)Galactosyl Epitope Provides Protection in Mice Challenged with Colon Cancer Cells Expressing {alpha}(1,3)Galactosyl-transferase: A Novel Suicide Gene for Cancer Gene Therapy. Cancer Res. 63: 987-993 [Abstract] [Full Text]
Lanteri, M., Giordanengo, V., Vidal, F., Gaudray, P., Lefebvre, J.-C. (2002). A complete {alpha}1,3-galactosyltransferase gene is present in the human genome and partially transcribed. Glycobiology 12: 785-792 [Abstract] [Full Text]
Sheikh, S., Parhar, R., Al-Mohanna, F. (2002). Rapid static adhesion of human naive neutrophil to naive xenoendothelium under physiologic flow is independent of Gal{alpha}1,3-gal structures. J. Leukoc. Biol. 71: 932-940 [Abstract] [Full Text]
Vetere, A., Donati, I., Campa, C., Semeraro, S., Gamini, A., Paoletti, S. (2002). Synthesis and characterization of a novel glycopolymer with protective activity toward human anti-{alpha}-Gal antibodies. Glycobiology 12: 283-290 [Abstract] [Full Text]
Deriy, L., Chen, Z.-c., Gao, G.-P., Galili, U. (2002). Expression of {alpha}-gal epitopes on HeLa cells transduced with adenovirus containing {alpha}1,3galactosyltransferase cDNA. Glycobiology 12: 135-144 [Abstract] [Full Text]
Chen, Z. C., Tanemura, M., Galili, U. (2001). Synthesis of {{alpha}}-gal epitopes (Gal{{alpha}}1-3Gal{beta}1-4GlcNAc-R) on human tumor cells by recombinant {{alpha}}1,3galactosyltransferase produced in Pichia pastoris. Glycobiology 11: 577-586 [Abstract] [Full Text]
Yamamoto, F., Yamamoto, M. (2001). Molecular genetic basis of porcine histo-blood group AO system. Blood 97: 3308-3310 [Abstract] [Full Text]
McBride, J. W., Corstvet, R. E., Breitschwerdt, E. B., Walker, D. H. (2001). Immunodiagnosis of Ehrlichia canis Infection with Recombinant Proteins. J. Clin. Microbiol. 39: 315-322 [Abstract] [Full Text]
SAMSTEIN, B., PLATT, J. L. (2001). Physiologic and Immunologic Hurdles to Xenotransplantation. J. Am. Soc. Nephrol. 12: 182-193 [Abstract] [Full Text]
Ohdan, H., Swenson, K. G., Kruger Gray, H. S., Yang, Y.-G., Xu, Y., Thall, A. D., Sykes, M. (2000). Mac-1-Negative B-1b Phenotype of Natural Antibody-Producing Cells, Including Those Responding to Gal{alpha}1,3Gal Epitopes in {alpha}1,3-Galactosyltransferase-Deficient Mice. J. Immunol. 165: 5518-5529 [Abstract] [Full Text]
Koma, M., Miyagawa, S., Honke, K., Ikeda, Y., Koyota, S., Miyoshi, S., Matsuda, H., Tsuji, S., Shirakura, R., Taniguchi, N. (2000). Reduction of the major xenoantigen on glycosphingolipids of swine endothelial cells by various glycosyltransferases. Glycobiology 10: 745-751 [Abstract] [Full Text]
Ni, Y., Powell, R., Turner, D. D., Tizard, I. (2000). Specificity and Prevalence of Natural Bovine Anti-Alpha Galactosyl (Galalpha 1-6Glc or Galalpha 1-6Gal) Antibodies. CVI 7: 490-496 [Abstract] [Full Text]
Yamada, K., Shimizu, A., Utsugi, R., Ierino, F. L., Gargollo, P., Haller, G. W., Colvin, R. B., Sachs, D. H. (2000). Thymic Transplantation in Miniature Swine. II. Induction of Tolerance by Transplantation of Composite Thymokidneys to Thymectomized Recipients. J. Immunol. 164: 3079-3086 [Abstract] [Full Text]
Chiou, S.-T., Chen, Y.-W., Chen, S.-C., Chao, C.-F., Liu, T.-Y. (2000). Isolation and Characterization of Proteins That Bind to Galactose, Lipopolysaccharide of Escherichia coli, and Protein A of Staphylococcus aureus from the Hemolymph of Tachypleus tridentatus. J. Biol. Chem. 275: 1630-1634 [Abstract] [Full Text]
LaTemple, D. C., Abrams, J. T., Zhang, S. Y., Galili, U. (1999). Increased Immunogenicity of Tumor Vaccines Complexed with Anti-Gal: Studies in Knockout Mice for {{alpha}}1,3Galactosyltransferase. Cancer Res. 59: 3417-3423 [Abstract] [Full Text]
Artrip, J. H., Kwiatkowski, P., Michler, R. E., Wang, S.-F., Tugulea, S., Ankersmit, J., Chisholm, L., McKenzie, I. F.�C., Sandrin, M. S., Itescu, S. (1999). Target Cell Susceptibility to Lysis by Human Natural Killer Cells Is Augmented by alpha (1,3)-Galactosyltransferase and Reduced by alpha (1,2)-Fucosyltransferase. J. Biol. Chem. 274: 10717-10722 [Abstract] [Full Text]
Lopez, M., Gazon, M., Juliant, S., Plancke, Y., Leroy, Y., Strecker, G., Cartron, J.-P., Bailly, P., Cerutti, M., Verbert, A., Delannoy, P. (1998). Characterization of a UDP-Gal:Galbeta 1-3GalNAc alpha 1,4-Galactosyltransferase Activity in a Mamestra brassicae Cell Line. J. Biol. Chem. 273: 33644-33651 [Abstract] [Full Text]
Irie, A., Koyama, S., Kozutsumi, Y., Kawasaki, T., Suzuki, A. (1998). The Molecular Basis for the Absence of N-Glycolylneuraminic Acid in Humans. J. Biol. Chem. 273: 15866-15871 [Abstract] [Full Text]
Yamamoto, M., Lin, X.-H., Kominato, Y., Hata, Y., Noda, R., Saitou, N., Yamamoto, F. (2001). Murine Equivalent of the Human Histo-blood Group ABO Gene Is a cis-AB Gene and Encodes a Glycosyltransferase with Both A and B Transferase Activity. J. Biol. Chem. 276: 13701-13708 [Abstract] [Full Text]